Skip to content

Clinical trials

Completed Rhabdomyosarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rhabdomyosarcoma Status: Completed Clear all

114 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20024
20033
20044
20052
20065
20078
20084
20093
20106
20118
20128
20133
20145
20157
20164
20175
20185
20192
20203
20213
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed114

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)26
Children's Oncology Group11
European Organisation for Research and Treatment of Cancer - EORTC10
St. Jude Children's Research Hospital7
Emory University4
Memorial Sloan Kettering Cancer Center4
Eisai Inc.3
Eli Lilly and Company3
City of Hope Medical Center2
Fred Hutchinson Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rhabdomyosarcoma114
Sarcoma73
Sarcoma, Ewing51
Osteosarcoma46
Neuroblastoma44
Sarcoma, Synovial27
Wilms Tumor27
Neurofibrosarcoma22
Liposarcoma21
Neuroectodermal Tumors, Primitive, Peripheral21

Trials

Showing 76 to 100 of 114. Each trial links to its page on Pharma Observatory.

14 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.